NCT03548818View on ClinicalTrials.gov

Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

May 16, 2018

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
Chronic Granulomatous Disease
Interventions
DRUG

Interferon Gamma-1B

Study function and biochemistry of neutrophils off the drug for one week and then 12 hours after first dose and fourth dose.

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT03548818 - Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease | Biotech Hunter | Biotech Hunter